← Evidence map

ArticleJournal of experimental & clinical cancer research : CR2016

miR-539 inhibits prostate cancer progression by directly targeting SPAG5.

Hongtuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

47 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27037000